Author reply
Intern Med J
.
2020 Apr;50(4):507-508.
doi: 10.1111/imj.14785.
Authors
Anosh Sivashanmugarajah
1
2
,
Jordan Fulcher
1
2
,
David Sullivan
3
,
Marshall Elam
4
,
Alicia Jenkins
1
5
,
Anthony Keech
1
2
Affiliations
1
NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.
2
Department of Cardiology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
3
NSW Health Pathology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
4
Department of Pharmacology, University of Tennessee, Knoxville, TN, USA.
5
Department of Medicine, University of Melbourne, St Vincent's Hospital, Melbourne, Victoria, Australia.
PMID:
32270619
DOI:
10.1111/imj.14785
No abstract available
Publication types
Letter
Comment
MeSH terms
Drug-Related Side Effects and Adverse Reactions*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Iatrogenic Disease
Substances
Hydroxymethylglutaryl-CoA Reductase Inhibitors